文献速递神经肿瘤功能神经外科

术中神经电生理监测与否对胶质瘤手术长期功能与肿瘤学结局的影响:单中心回顾性队列研究

Long-Term Functional and Oncologic Outcomes of Glioma Surgery with and without Intraoperative Neurophysiologic Monitoring: A Retrospective Cohort Study in a Single Center.
PubMed 文献 · World Neurosurg · 2018-07-17

该单中心回顾性队列纳入2010年10月至2016年3月接受肿瘤切除的856例胶质瘤患者,按是否应用术中神经电生理监测(IONM)分为IONM组439例与非IONM组417例。单因素分析显示IONM组总生存期长于非IONM组(P=0.036),尤其在高分级星形细胞肿瘤患者中(P=0.034);多因素分析显示IONM是总生存期(比值比0.776;P=0.046)和晚期神经功能(比值比0.583;P=0.039)的有利因素。结论认为应用IONM有利于胶质瘤患者的长期功能与肿瘤学结局。

要点

  • IONM组总生存期长于非IONM组(P=0.036),高分级星形细胞肿瘤患者中亦见延长(P=0.034)。
  • IONM组神经功能缺损率低于非IONM组。
  • 多因素分析示IONM为总生存期(比值比0.776;P=0.046)和晚期神经功能(比值比0.583;P=0.039)的有利因素。

核心结论

  • 应用IONM有利于胶质瘤患者的长期功能与肿瘤学结局。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010年10月至2016年3月接受肿瘤切除的856例胶质瘤患者,分为IONM组439例与非IONM组417例。
  • 主要结局为总生存期,次要结局为晚期神经功能缺损率,采用单因素检验、多因素logistic回归和Cox比例风险模型分析。

主要发现

  • 单因素生存分析显示IONM组总生存期长于非IONM组(P=0.036),尤其在高分级星形细胞肿瘤患者中(P=0.034)。
  • IONM组神经功能缺损率低于非IONM组。
  • 多因素分析显示IONM是总生存期的有利因素(比值比0.776;P=0.046)。
  • 多因素分析显示IONM是晚期神经功能的有利因素(比值比0.583;P=0.039)。
  • 优势半球及 eloquent 区胶质瘤与总生存期无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate long-term functional and survival outcomes of patients with glioma after intraoperative neurophysiologic monitoring (IONM) application. METHODS: A total of 856 patients with glioma, who underwent tumor resection between October 2010 and March 2016, were included in this retrospective cohort study. All patients were stratified into IONM (439 patients) and non-IONM groups (417 patients). The primary outcome measured was overall survival (OS), and the secondary outcome measured was rate of late neurologic deficits. Analyses were performed using univariate tests and multivariate logistic regression and Cox proportional hazard model. RESULTS: The 2 cohorts were well balanced with respect to baseline characteristics. Univariate survival analysis showed longer OS in the IONM group than that in the non-IONM group (P = 0.036), especially in patients with high-grade astrocytic tumor (P = 0.034). The IONM group showed a lower rate of neurologic deficits than did the non-IONM group. Multivariate analysis showed that IONM was a favorable factor of OS (odds ratio, 0.776; P = 0.046) and late neurologic function (odds ratio, 0.583; P = 0.039). Dominant hemispheric and eloquent location of glioma had no association with OS. CONCLUSIONS: Application of IONM is beneficial to long-term functional and oncologic outcomes of patients with glioma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zhang N, Yu Z, Hameed NUF, et al. Long-Term Functional and Oncologic Outcomes of Glioma Surgery with and without Intraoperative Neurophysiologic Monitoring: A Retrospective Cohort Study in a Single Center. World Neurosurg. 2018. PMID: 30026163. doi:10.1016/j.wneu.2018.07.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。